Clene Inc (CLNN) is trading 15% higher at $3.31 today.

Clene Inc has been trading between a 52-week high of $13.69 and a 52-week low of $1.93. The stock has a market cap of $209 Million.

Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses.

PAYO, MRNS and CLNN are among pre market gainers
Seeking Alpha 07-14-22

EVFM, DTIL and SRRK among mid-day movers
Seeking Alpha 06-27-22

BTCM, ANTE and CLNN among mid-day movers
Seeking Alpha 06-13-22

Clene Inc. (NASDAQ:CLNN) Has Already Recovered 53.16%, But Another -332.52% Drop Cannot Be Ruled Out.
Marketing Sentinel 06-11-22

New Data from Clene''s RESCUE-ALS Study to be Presented at 2022 ENCALS Meeting
Benzinga 06-01-22